Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.

S. S. Shin(Brigham and Women's Hospital), Salmaan Keshavjee(Brigham and Women's Hospital), V. T. Golubchikova, Askar Yedilbayev(World Health Organization Regional Office for Europe), Alexander Pasechnikov, Sergey P. Mishustin, Michael Rich, Alexander Barnashov, Joia S. Mukherjee(Harvard University), Y Karpeichik, G G Peremitin, Tamara P. Tonkel, G. V. Yanova, Paul E. Farmer(Partners In Health), S Atwood, А. К. Стрелис, Irina Gelmanova, Yevgeny G Andreev, Jennifer Furin

PubMed

December 1, 2007

Cited by 130

Related Papers

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

|Clinical Infectious Diseases|2016|1.5k

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

|The Lancet|2018|639

Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection

|The Journal of Experimental Medicine|2001|385

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

|Clinical Infectious Diseases|2016|321

Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe

|European Respiratory Journal|2019|130